LADR cells are a newly re-established human mast cell line derived from a second aspiration of the same patient who contributed to the LAD2 (Cat. T8157) line. LADR cells are larger, more granulated, and exhibit a slower proliferation rate compared to LAD2 cells. They are characterized by increased expression of Fc?RI and CD117, higher tryptase levels, and additional surface markers such as CD13, CD123, CD184, and CD195. These characteristics suggest that LADR cells are more advanced and mature, making them a unique model for studying mast cell biology, particularly in advanced stages of development. Additionaly, cells are susceptible to T-tropic, M-tropic, and dual tropic HIV infection. LADR cells are valuable for research in allergy, immunology, and infectious diseases. Their distinct expression profile and functional responses make them suitable for studies on mast cell activation, signaling, and interaction with pathogens, such as HIV. The unique properties of LADR cells, including their slower proliferation and higher granularity, offer additional insights into mast cell maturation and function, complementing studies performed with LAD2 cells.LADR cells differ from LAD2 cells in their slower proliferation, increased granulation, and higher expression of certain surface markers and tryptase. These differences enhance the utility of LADR cells in specific research areas where these attributes are advantageous, providing a more mature and advanced model for studying certain aspects of mast cell biology.
Note: understanding the recommended culture conditions and expected behaviour of this cell line are critical for establishing a successful culture.?br />Additional cell lines of interest:Cat. T8157 -?uman Mast Cell Line (LAD2)
Cell Type
Tumor Cells
Biosafety Level
2
Depositor
NIH (NIAID)
Disclaimer
1. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 ?g, Cat.# C207, $450.00) or cell lysate (100 ?g, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final. 2. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping). 3. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information. 4. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate. 5. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."
Suspension; Rounded, granulated; some large aggregates at higher densities
Growth Conditions
PriCoat?T25 Flasks (G299) are recommended for optimal cell culture.?riGrow X Series Medium for T8156 (TM8156) + 100ng/ml human Stem Cell Factor (Z100815) + 2mM L-Glutamine (G275) + 1% Penicillin/Streptomycin Solution (G255), 37.0?, 5% CO?.?ote: Thaw cells in a T25; remove debris during the first week post-thaw by skimming, where possible. It is normal to observe cell death in the first two-three weeks after thawing. Allow cells to recover under the recommended culture conditons.?eplace half of the medium with an equal volume of fresh medium, weekly. Cells are slow-growing and extremely sensitive to mycoplasma contamination; routine testing should be performed.?o not allow cells to become over-confluent or grow past a density of 1x106?ells/ml.*Cells may lose functionality as a result of continous culture.?egranulation assays must be conducted every 2 months to test functionality -protocol can be found under the "Documents" tab.
Tissue
Bone Marrow
Notes
1. Visually examine the packaging containers for signs of leakage or breakage. 2. Immediately transfer frozen cells from dry ice packaging to a temperature below -130?, preferably in liquid nitrogen vapor phase storage, until ready for use.To ensure the highest level of viability, thaw the vial and initiate culture as soon as possible upon receipt. If continued storage is desired, the vial should only be stored below -130? or in liquid nitrogen vapor phase. Do not store at -70?, as it will result in loss of viability.
Organism
Human (H. sapiens)
Cryopreservation
Following centrifugation, leave a small amount of culturing media (50-100 uL) and add non-DMSO, non-FBS containing CryoScarless Cryopreservative (BioVerde) at a final concentration of 5x106 cells/mL. Place vials in a cryo container and store at -80? or in liquid nitrogen for longer preservation.
Applications Range
Research Use Only.
Shipping
Ship with dry ice.
Product Format
Frozen
Product Use
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
Storage
Vapor phase of liquid nitrogen, or below -130?.
Thawing Protocol
1. Thaw cells quickly in a 37? water bath while agitating gently (maximum 2 minutes). The vial cap should be kept above the water level to minimize the risk of contamination. 2. Decontaminate the vial by spraying and wiping the exterior of the vial with 70% ethanol. From this point onwards, all operations should be strictly carried out inside a biological safety cabinet using aseptic conditions. 3. Transfer the cell suspension into a 15ml sterile conical tube containing 5ml of pre-warmed, complete growth media. Centrifuge cells at 850rpm for 5 minutes. 4. Aspirate the supernatant without disturbing the cell pellet. Re-suspend the cell pellet in the recommended pre-warmed, complete growth media and dispense into a T25 culture flask. 5. Incubate the cells at the recommended conditions.?ost-thaw viability should be 70-95% in the first 24 hours. However, this is expected to decrease over the next 2-3 weeks as LADR cells are sensitive to post-thaw conditions and undergo significant death.? 6. Debris is expected and should be removed during the first week post-thaw by skimming, where possible. Hemidepletion of media should be performed weekly. Do not perform a complete media change. Allow cells to recover.
Subculture Protocol
1. Transfer expanding cultures to T75 or larger culture vessels to keep cell densities between 5x105?1x106?ells/ml. Do not exceed?x106?ells/ml.2.?emove half the volume of the culture media and replace with fresh media (hemidepletion) the first or second week after thawing. Remove debris by skimming media, if possible. It is normal to see increased cell death for the first 2-3 weeks following thawing. 3. Alternatively, collect cells and centrifuge (750-850 rpm for 5 min) to form a pellet. Discard half the supernatant and re-suspend the cell pellet in the remaining media. Add fresh complete media at a 1:1 ratio and aliquot the cell suspension to new culture vessels, as desired. 4. Incubate the cells at the recommended conditions. Allow cells to recover and perform hemi-depletions with fresh growth media, weekly.